JBS N.V. research snapshot
JBS AI stock analysis currently reads JBS N.V. as a large, diversified animal-protein processor whose scale spans beef, pork, poultry, prepared foods, and multiple geographies. Fiscal 2025 revenue reached $86.18 billion and net income attributable to JBS was $2.02 billion, but first-quarter 2026 profitability weakened as North American beef and Pilgrim's Pride faced pressure. At the August 2, 2026 data cutoff, the latest accessible quote reference was $14.02 from the July 31, 2026 close and market capitalization was about $15.0 billion. The stock has moved above its 50-day moving average and analyst consensus is Buy with an average target near $18.11, but the low earnings multiple still needs to be weighed against $21.01 billion of net debt, a negative first-quarter free cash flow result, and material governance and ESG risks. This JBS AI stock analysis is informational only and is not investment advice.
Current price
$14.02
Market cap
$15.01 billion, verified from price and 1.07 billion shares
AI score
62 / 100
Rating
Global protein scale at a low earnings multiple with a recovering technical trend, offset by cattle-cycle losses, negative quarterly free cash flow, high net debt, and governance concentration
Trend status
Improving near-term trend: price is above the 50-day moving average with RSI near 69, but still below the 200-day moving average
Data cutoff (updated monthly)
August 4, 2026
Informational use only. This page is not investment advice.
| Dimension | Conclusion | Confidence |
|---|---|---|
| Business quality | JBS processes and sells beef, pork, lamb, poultry, prepared foods, leather, collagen, packaging, biodiesel, and related products across the Americas, Australia, Europe, and other markets. | High |
| Moat | Scale, global sourcing, processing assets, distribution, brands, customer relationships, and a multi-protein portfolio matter, but commodity spreads and retailer bargaining power limit pricing durability. | Medium |
| Management | CEO Gilberto Tomazoni leads a global operating platform, while the Batista family retains concentrated control through Class B shares. Capital allocation, debt reduction, and governance remain central tests. | Medium |
| Financial trend | Fiscal 2025 sales grew 11.7% to $86.18 billion and net income rose to $2.02 billion, but Q1 2026 adjusted EBITDA fell 26% year over year and free cash flow was negative $1.5 billion. | High |
| Valuation | At $14.02, financial_rigor.py calculates about 8.65x TTM EPS, 1.82x book value, 50.07x TTM free cash flow per share, and a 14.27% indicated dividend yield. | High |
| Technical trend | The setup improved. StockAnalysis listed a $12.39 50-day average, a $14.44 200-day average, and a 69.21 RSI against the $14.02 July 31, 2026 close, with price above the 50-day average. | Medium-high |
| Risk level | Risk is high because JBS combines protein-cycle volatility, leverage, working-capital demands, food and labor risks, litigation and regulation, environmental exposure, and dual-class control. | High |
| AI confidence | Historical data confidence is high, while forecast confidence is medium-low because earnings depend on cattle, feed, poultry, export, currency, and capital-market conditions. | High data confidence |
| Investment certainty | A low multiple is not by itself a margin of safety. Investment certainty improves only if cash conversion and beef profitability recover while leverage and governance risks stay contained. | Low-medium |
JBS AI stock forecast
The JBS AI stock forecast uses scenario math around the $14.02 quote and $1.62 TTM EPS. The audited three-year framework produced values near $22.80 in the bullish case, $15.00 in the base case, and $9.70 in the bearish case before dividends. These are scenario outputs, not price promises, and the stock already rose about 19% between the July 11 and August 2, 2026 checks.
$20 to $24
More likely if North American beef spreads recover as the cattle cycle normalizes, Seara and USA Pork sustain margins, Pilgrim's Pride operations improve, free cash flow turns positive, net leverage declines, and investors apply about 10x higher earnings.
$13 to $17
More likely if earnings stay near flat to low single digits, beef remains difficult but does not deteriorate further, other protein units offset part of the pressure, cash conversion recovers after seasonal working-capital use, and the market applies about 8x earnings.
$8 to $12
More likely if cattle costs and weak spreads persist, poultry margins soften, working capital consumes cash, debt stays elevated, dividend coverage tightens, or governance and ESG events raise the risk premium toward a 6x earnings multiple.
JBS AI technical analysis
JBS AI technical analysis improved as of the August 2, 2026 data cutoff. The latest accessible July 31, 2026 close was $14.02, above the StockAnalysis 50-day moving-average reference of $12.39 but still below the 200-day reference of $14.44. RSI of 69.21 shows strengthening momentum after the recovery off the July lows, though it is no longer an oversold signal.
| Level | Value | Why it matters |
|---|---|---|
| Current price | $14.02 | StockAnalysis July 31, 2026 close used in market-cap verification. |
| Near support | $12.39 | StockAnalysis 50-day moving-average reference. The first zone to monitor if the rally pauses. |
| Lower support | $11.50 to $12 | The July consolidation area rather than a vendor-derived pivot. Confirm it with live chart data before acting. |
| Near resistance | $14.44 | StockAnalysis 200-day moving-average reference as of the cutoff. A durable reclaim would be stronger trend evidence. |
| Higher resistance | $14.86 to $15 | Near the low end of analyst price targets and a round-number zone. Watch whether buyers defend or reject this area. |
| Moving averages | 50-day $12.39 and 200-day $14.44 | Price was above the 50-day and slightly below the 200-day in the latest available snapshot. |
| Momentum | RSI 69.21 | Momentum strengthened after the July rebound, moving from near oversold toward overbought. |
| Volume | 20-day average 4.68 million shares | Watch whether a move above $14.44 occurs with materially stronger-than-average volume. |
| Volatility | Event and commodity sensitive | Earnings, cattle pricing, currency, dividend news, ESG headlines, and regulatory developments can widen volatility. |
| Invalidation | Failure to hold the $12.39 50-day area | A sustained break below the 50-day moving average would weaken the recovery thesis. |
JBS AI trading strategy
The JBS AI trading strategy is a rules-based research framework, not personalized advice. It links price action to cattle spreads, protein margins, cash conversion, leverage, working capital, dividend policy, governance disclosures, and regulatory or ESG developments.
Wait for JBS to reclaim and hold the $14.44 200-day area on stronger-than-average volume, with supporting evidence that beef losses are narrowing and group cash flow is recovering.
A failed reclaim or a close back below the $12.39 50-day support zone weakens the setup. Avoid treating the post-recovery P/E as technical confirmation.
If JBS pulls back toward the $12.39 50-day area, compare live price with updated earnings, free cash flow, net debt, cattle costs, segment margins, and dividend coverage before considering a reversal thesis.
Do not chase the stock after the recent sharp rally solely on momentum. A lower entry still depends on cash conversion and beef profitability, not on price alone.
Track JBS Beef North America spreads, Seara margin, USA Pork profit, Pilgrim's Pride results, working capital, capex, free cash flow, net leverage, debt maturities, dividends, share count changes, Class A and Class B ownership, and environmental and legal disclosures.
Size risk for a cyclical, highly levered protein processor. Reassess if free cash flow stays negative outside the normal seasonal pattern, if dividend coverage tightens, or if governance and regulatory risks intensify.
Investment research summary
Customers pay JBS for dependable supply of animal protein and related food products across retail, foodservice, industrial, and export channels. The business earns when procurement, plant utilization, yield, logistics, branded products, and protein spreads work together.
JBS has scale in sourcing, slaughter and processing capacity, distribution, multi-country operations, brands such as Seara and Pilgrim's, and customer relationships. This is a scale moat, not a permanent pricing-power moat, because livestock and feed markets can compress margins quickly.
The thesis fails if cattle availability keeps U.S. beef spreads negative, poultry demand or margins weaken, working capital repeatedly consumes cash, debt constrains flexibility, food-safety or labor events disrupt operations, or governance and environmental controversy raise the cost of capital.
Gilberto Tomazoni leads a broad operating group with recurring tests in capital allocation, debt discipline, portfolio integration, and environmental controls. The Batista family controls 85.68% of aggregate voting power through the dual-class structure, so minority shareholders must weigh execution against control concentration.
Global protein demand can grow with population, incomes, convenience foods, and export trade, but it remains cyclical. Cattle supply, feed, disease, trade restrictions, currency, consumer affordability, retailer power, labor, and regulation can outweigh secular volume growth in any year.
At about 8.65x TTM EPS, JBS looks inexpensive on earnings and carries a high 14.27% indicated dividend yield, but TTM free cash flow per share was only $0.28. The margin of safety depends on normalized cash conversion and debt reduction, not on the headline multiple or yield alone.
Source-backed data
Every metric below includes a source and last verification date.
| Metric | Value | Source | Last verified |
|---|---|---|---|
| Fiscal 2025 revenue and net income | $86.184 billion revenue and $2.024 billion net income attributable to JBS | JBS fiscal 2025 earnings release filed with the SEC | August 2, 2026 |
| Fiscal 2025 free cash flow and leverage | $400 million free cash flow and 2.4x net debt to adjusted EBITDA | JBS fiscal 2025 earnings release filed with the SEC | August 2, 2026 |
| Q1 2026 revenue, EBITDA, net income, and EPS | $21.609 billion revenue, $1.133 billion IFRS adjusted EBITDA, $221 million net income, and $0.21 EPS | JBS Q1 2026 earnings release filed with the SEC | August 2, 2026 |
| Q1 2026 segment and cash-flow context | North American beef adjusted EBITDA was negative $267 million and quarterly free cash flow was negative $1.5 billion | JBS Q1 2026 earnings release filed with the SEC | August 2, 2026 |
| Cash and basic shares outstanding | $3.295 billion cash and 1.071 billion weighted-average basic shares at March 31, 2026 | JBS Q1 2026 interim financial statements filed with the SEC | August 2, 2026 |
| TTM fundamentals and technical indicators | $88.27 billion revenue, $1.62 EPS, $3.29 billion cash, $24.30 billion debt, $296.18 million free cash flow, 50-day $12.39, 200-day $14.44, RSI 69.21 | StockAnalysis statistics | August 2, 2026 |
| Market capitalization verification | $15.01 billion verified as $14.02 multiplied by 1.07 billion shares, a 0.04% difference from reported market cap | financial_rigor.py and StockAnalysis market capitalization | August 2, 2026 |
| Analyst consensus | Consensus Buy with an $18.11 average price target from 15 analysts, range $14.86 to $20.21 | StockAnalysis forecast based on S&P Global Market Intelligence | August 2, 2026 |
| Voting control | Joesley and Wesley Batista held 100% of Class B shares and 31.28% of Class A shares, representing 85.68% of aggregate voting power | JBS 2025 Form 20-F summary | August 2, 2026 |
This JBS AI stock analysis page is an informational research tool only. It is not investment advice, a recommendation, or a guarantee of future returns. Forecast scenarios are based on available data as of the cutoff date and can be wrong if JBS fundamentals, protein markets, leverage, governance, regulatory exposure, or market conditions change.
Design trading strategies visually with 10+ indicators. Set entry/exit conditions and risk management, then generate Pine Script code with no coding required.
Filter and discover stocks based on market cap, dividend yield, P/E ratio, sector, and more. Screen thousands of stocks with real-time data.
Smart AI-driven stock selection with fundamental screening, analyst estimates, and key metrics. Filter by P/E, market cap, dividends, and more.
